Regulation of myeloid cell function by a novel putative lncRNA

一种新型推定lncRNA调节骨髓细胞功能

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT Understanding the mechanisms that underlie the function and regulation of immune cells in health and disease is critical to developing therapies aimed at modulating their function. Innate immune cells such as macrophages represent a critical arm of the immune system. These cells not only represent the front line of defense against microbes, but also mediate critical effector functions at the direction of the adaptive immune system. Dysregulation of such effector functions can lead to pathogenic inflammation and tissue damage, as seen in septic shock, an acute condition that results in the death in one out of three affected patients. Thus, understanding the functional regulation of these cells can help to develop therapeutic interventions for such diseases. Classical protein coding genes represent the minority of genetic elements in the eukaryotic genome, and yet these genes have been the focus of the vast majority of functional studies to date, including those investigating innate immune cell function. Surprisingly, the number of such genes does not increase with organismal complexity, while the number of so-called non-coding genes does. This suggests that the latter genes execute complex cell type-specific regulator functions. A class of such genes, called long non-coding RNAs (lncRNAs) have recently emerged as critical regulators of immune cell function. We have identified such a lncRNA, called U90926, as almost exclusively expressed in activated myeloid cells. The function of this gene is unknown. We have generated mice deficient in this gene, and we propose an experimental plan to functionally dissect the role of this gene in myeloid cell effector function, both in vitro and in vivo, in clinically relevant models of human inflammatory disease.
项目摘要/摘要 了解免疫细胞在健康和疾病中的功能和调节的机制 对于开发旨在调节其功能的疗法至关重要。先天免疫细胞,例如巨噬细胞 代表免疫系统的关键部门。这些牢房不仅代表了防御的前线 微生物,但还介导了自适应免疫系统方向的关键效应子功能。 这种效应功能的失调可能会导致致病性炎症和组织损伤,如 败血性休克,一种急性疾病,导致三名受影响的患者中的一名死亡。因此, 了解这些细胞的功能调节可以帮助开发这种治疗性干预措施 疾病。经典蛋白质编码基因代表真核基因组中的遗传因素的少数, 然而,这些基因一直是迄今为止绝大多数功能研究的重点,包括 研究先天免疫细胞功能。令人惊讶的是,此类基因的数量不会随着 生物复杂性,而所谓的非编码基因的数量确实如此。这表明后一个基因 执行复杂的单元格特定调节器函数。一类这样的基因,称为长非编码RNA (LNCRNA)最近已成为免疫细胞功能的关键调节剂。我们已经确定了这样的 lncRNA,称为U90926,几乎仅在活化的髓样细胞中表达。该基因的功能是 未知。我们已经产生了该基因缺乏的小鼠,我们提出了一个实验计划来在功能上 在体外和体内剖析该基因在髓样细胞效应函数中的作用,在临床相关模型中 人类炎症性疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Dimitry N Krements...的其他基金

Novel mouse models to dissect the role of genetics, sex, and environment in heterogeneous outcomes in CNS autoimmune disease
新型小鼠模型可剖析遗传、性别和环境在中枢神经系统自身免疫性疾病异质性结果中的作用
  • 批准号:
    10680560
    10680560
  • 财政年份:
    2022
  • 资助金额:
    $ 19.12万
    $ 19.12万
  • 项目类别:
Novel mouse models to dissect the role of genetics, sex, and environment in heterogeneous outcomes in CNS autoimmune disease
新型小鼠模型可剖析遗传、性别和环境在中枢神经系统自身免疫性疾病异质性结果中的作用
  • 批准号:
    10538863
    10538863
  • 财政年份:
    2022
  • 资助金额:
    $ 19.12万
    $ 19.12万
  • 项目类别:
Regulation of myeloid cell function by a novel putative lncRNA
一种新型推定lncRNA调节骨髓细胞功能
  • 批准号:
    10372592
    10372592
  • 财政年份:
    2021
  • 资助金额:
    $ 19.12万
    $ 19.12万
  • 项目类别:
Next generation systems analysis of pathogenetic mechanisms underlying CNS autoimmunity
中枢神经系统自身免疫发病机制的下一代系统分析
  • 批准号:
    9768066
    9768066
  • 财政年份:
    2019
  • 资助金额:
    $ 19.12万
    $ 19.12万
  • 项目类别:
Interactions Between Host Genetics and the Gut Microbiome in CNS Autoimmunity
中枢神经系统自身免疫中宿主遗传学与肠道微生物组之间的相互作用
  • 批准号:
    10093145
    10093145
  • 财政年份:
    2017
  • 资助金额:
    $ 19.12万
    $ 19.12万
  • 项目类别:

相似海外基金

T-bet-regulated myeloid innate defense against Toxoplasma gondii
T-bet 调节的骨髓对弓形虫的先天防御
  • 批准号:
    10660458
    10660458
  • 财政年份:
    2023
  • 资助金额:
    $ 19.12万
    $ 19.12万
  • 项目类别:
The role of plasmacytoid dendritic cells in corneal immunity
浆细胞样树突状细胞在角膜免疫中的作用
  • 批准号:
    10640026
    10640026
  • 财政年份:
    2023
  • 资助金额:
    $ 19.12万
    $ 19.12万
  • 项目类别:
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
针对分子定义的难治性黑色素瘤子集的新型细胞治疗方法
  • 批准号:
    10780289
    10780289
  • 财政年份:
    2023
  • 资助金额:
    $ 19.12万
    $ 19.12万
  • 项目类别:
Evaluating the interaction of the immune system and inflammation on the progression of blast-mediated neurodegeneration.
评估免疫系统和炎症对急变介导的神经变性进展的相互作用。
  • 批准号:
    10326408
    10326408
  • 财政年份:
    2021
  • 资助金额:
    $ 19.12万
    $ 19.12万
  • 项目类别:
Transcriptional regulation of T cell immunity
T细胞免疫的转录调控
  • 批准号:
    10341041
    10341041
  • 财政年份:
    2021
  • 资助金额:
    $ 19.12万
    $ 19.12万
  • 项目类别: